In the past week, TNDM stock has gone up by 26.90%, with a monthly gain of 34.82% and a quarterly surge of 92.59%. The volatility ratio for the week is 6.60%, and the volatility levels for the last 30 days are 5.39% for Tandem Diabetes Care Inc. The simple moving average for the past 20 days is 31.32% for TNDM’s stock, with a 72.45% simple moving average for the past 200 days.
Is It Worth Investing in Tandem Diabetes Care Inc (NASDAQ: TNDM) Right Now?
Additionally, the 36-month beta value for TNDM is 1.20. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 5 rating it as “hold,” and 1 rating it as “sell.”
The public float for TNDM is 64.15M and currently, short sellers hold a 14.41% ratio of that float. The average trading volume of TNDM on May 06, 2024 was 1.80M shares.
TNDM) stock’s latest price update
Tandem Diabetes Care Inc (NASDAQ: TNDM) has experienced a rise in its stock price by 22.32 compared to its previous closing price of 36.56. However, the company has seen a gain of 26.90% in its stock price over the last five trading days. The Motley Fool reported 2024-05-03 that Tandem Diabetes Care beat earnings — but only by losing less money than expected — on Thursday. On the plus side, sales jumped much higher than expected.
Analysts’ Opinion of TNDM
Many brokerage firms have already submitted their reports for TNDM stocks, with Wells Fargo repeating the rating for TNDM by listing it as a “Overweight.” The predicted price for TNDM in the upcoming period, according to Wells Fargo is $45 based on the research report published on April 29, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see TNDM reach a price target of $45, previously predicting the price at $34. The rating they have provided for TNDM stocks is “Outperform” according to the report published on April 25th, 2024.
Stifel gave a rating of “Buy” to TNDM, setting the target price at $37 in the report published on March 26th of the current year.
TNDM Trading at 40.77% from the 50-Day Moving Average
After a stumble in the market that brought TNDM to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 10.12% of gains for the given period.
Volatility was left at 5.39%, however, over the last 30 days, the volatility rate increased by 6.60%, as shares surge +32.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +78.88% upper at present.
During the last 5 trading sessions, TNDM rose by +26.90%, which changed the moving average for the period of 200-days by +41.56% in comparison to the 20-day moving average, which settled at $34.61. In addition, Tandem Diabetes Care Inc saw 51.18% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TNDM starting from Allen Dick, who purchase 5,000 shares at the price of $18.96 back on Nov 27 ’23. After this action, Allen Dick now owns 19,962 shares of Tandem Diabetes Care Inc, valued at $94,778 using the latest closing price.
Vosseller Leigh, the EVP & CHIEF FINANCIAL OFFICER of Tandem Diabetes Care Inc, purchase 6,200 shares at $15.39 during a trade that took place back on Nov 08 ’23, which means that Vosseller Leigh is holding 11,860 shares at $95,395 based on the most recent closing price.
Stock Fundamentals for TNDM
Current profitability levels for the company are sitting at:
- -0.19 for the present operating margin
- 0.49 for the gross margin
The net margin for Tandem Diabetes Care Inc stands at -0.18. The total capital return value is set at -0.2. Equity return is now at value -48.62, with -14.93 for asset returns.
Based on Tandem Diabetes Care Inc (TNDM), the company’s capital structure generated 0.6 points at debt to capital in total, while cash flow to debt ratio is standing at -0.06. The debt to equity ratio resting at 1.5. The interest coverage ratio of the stock is 37.38.
Currently, EBITDA for the company is -118.22 million with net debt to EBITDA at -3.37. When we switch over and look at the enterprise to sales, we see a ratio of 4.29. The receivables turnover for the company is 8.28for trailing twelve months and the total asset turnover is 0.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.81.
Conclusion
In conclusion, Tandem Diabetes Care Inc (TNDM) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
